Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients

Mucosal Immunology

Volumn 5, Issue 2, 2012, Pages 140-149

  Bellini, A ^a   Marini, M A ^b   Bianchetti, L ^a   Barczyk, M ^a   Schmidt, M ^a   Mattoli, S ^a  

^a Scientific Direction and Project Management Avail Biomedical Research Institute   (Switzerland)

^b Multispecialty Outpatient Clinic and Diagnostic Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA SMOOTH MUSCLE ACTIN; BUDESONIDE; COLLAGEN; FLUTICASONE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; MOMETASONE FUROATE;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL COUNT; CELL ISOLATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; FEMALE; FIBROCYTE; HUMAN; HUMAN CELL; MALE; MESENCHYME CELL; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; SPUTUM; TH17 CELL; TH2 CELL;

EID: 84857215266     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.60     Document Type: Article

References (49)

1. National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J. Allergy Clin. Immunol. 120 (5 Suppl), S94-S138 (2007).
2. Jeffery, P. K. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164, S28-S38 (2001).
3. Benayoun, L ., Druilhe, A ., Dombret, M. C ., Aubier, M. & Pretolani, M. Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit Care Med. 167, 1360-1368 (2003). (Pubitemid 36609720)
4. Cohn, L ., Elias, J. A. & Chupp, G. L. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789-815 (2004). (Pubitemid 38680442)
5. Saglani, S. et al. Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants. Eur. Respir. J. 28, 505-512 (2006). (Pubitemid 44794664)
6. Wenzel, S. E. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 160, 1001-1008 (1999). (Pubitemid 29442043)
7. Woodruff, P. G. et al. T-helper type-2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180, 388-395 (2009).
8. Berry, M. et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 62, 1043-1049 (2007). (Pubitemid 350206195)
9. Roche, W. R ., Beasley, R ., Williams, J. H. & Holgate, S. T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1, 520-524 (1989). (Pubitemid 19075206)
10. Boulet, L .- P. et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112, 45-52 (1997). (Pubitemid 27343598)
11. Roberts, C. R. Is asthma a fibrotic disease? Chest 107, 111S-117S (1995).
12. Wilson, J. W. & Li, X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin. Exp. Cytol. 65, 109-126 (2002).
13. Pini, L. et al. Differences in proteoglycans deposition in the airways of moderate and severe asthmatics. Eur. Respir. J. 29, 71-77 (2007). (Pubitemid 46092000)
14. Brewster, C. E. P ., Howarth, P. H ., Djukanovic, R ., Wilson, J ., Holgate, S. T. & Roche, W. R. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 3, 507-511 (1990).
15. Mattoli, S ., Bellini, A. & Schmidt, M. The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy. Curr. Stem Cell Res. Ther. 4, 266-280 (2009).
16. Bellini, A. & Mattoli, S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest. 87, 858-870 (2007). (Pubitemid 47267815)
17. Reilkoff, R. A ., Bucala, R. & Herzog, E. L. Fibrocytes: emerging effector cells in chronic inflammation. Nat. Rev. Immunol. 11, 427-435 (2011).
18. Bianchetti, L ., Barczyk, M ., Cardoso, J ., Schmidt, M ., Bellini, A. & Mattoli, S. Extracellular matrix remodelling properties of fibrocytes. J. Cell. Mol. Med (2011 ) DOI: 10.1111/j.1582-4934.2011.01344.x.
19. Schmidt, M ., Sun, G ., Stacey, M. A ., Mori, L. & Mattoli, S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171, 380-389 (2003). (Pubitemid 36745311)
20. Kariyawasam, H. H ., Aizen, M ., Barkans, J ., Robinson, D. S. & Kay, A. B. Remodeling and airway hyperesponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 175, 896-904 (2007). (Pubitemid 46684699)
21. Nihlberg, K ., Larsen, K ., Hultgårdh-Nilsson, A ., Malmström, A ., Bjermer, L. & Westergren-Thorsson, G. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir. Res. 7, 50 (2006).
22. Saunders, R. et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J. Allergy Clin. Immunol. 123, 376-384 (2009).
23. Alcorn, J. F ., Crowe, C. R. & Kolls, J. K. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 72, 495-516 (2010).
24. Wiehler, S. & Proud, D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L505-515 (2007). (Pubitemid 47205032)
25. Shin, T .- S. et al. Role of inducible nitric oxide synthase on the development of virus-associated asthma exacerbation which is dependent on Th1 and Th17 cell responses. Exp. Mol. Med. 42, 721-730 (2010).
26. Reddel, H. K. et al. An official american thoracic society/european respiratory society statement: asthma control and exacerbations. Am. J. Respir. Crit. Care Med. 180, 59-99 (2009).
27. Khurana Hershey, G. K. IL-13 receptors and signalling pathways: an evolving web. J. Allergy Clin. Immunol. 111, 677-690 (2003). (Pubitemid 36470232)
28. Elias, J. A. & Lee, C. G. IL-13 in asthma. The successful integration of lessons from mice and humans. Am. J. Respir. Crit. Care Med. 183, 957-958 (2011).
29. Wang, C .- H. et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 178, 583-591 (2008).
30. Heijink, I. H. & van Oosterhout, A. J. Targeting T cells for asthma. Curr. Opin. Pharmacol. 5, 227-231 (2005). (Pubitemid 40674243)
31. Kuipers, H. & Lambrecht, B. N. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr. Opin. Immunol. 16, 702-708 (2004). (Pubitemid 39423657)
32. Kay, A. B. The role of T lymphocytes in asthma. Chem. Immunol. Allergy 91, 59-75 (2006). (Pubitemid 43097196)
33. Komai, M. et al. Role of Th2 responses in the development of allergeninduced airway remodelling in a murine model of allergic asthma. Br. J. Pharmacol. 138, 912-920 (2003). (Pubitemid 36390648)
34. Wills-Karp, M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202, 175-190 (2004). (Pubitemid 39576912)
35. Lee, C. G. et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809-821 (2001).
36. Shao, D. D ., Suresh, R ., Vakil, V ., Gomer, R. H. & Pilling, D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J. Leukoc. Biol. 83, 1323-1333 (2008). (Pubitemid 351960310)
37. Zhao, Y ., Yang, J ., Gao, Y. & Guo, W. Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 151, 297-307 (2010).
38. Bullens, D. M. et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocyte influx? Respir. Res. 7, 135 (2006).
39. Molet, S. et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108, 430-438 (2001). (Pubitemid 32881066)
40. Barnes, P. J. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 118, 3546-3556 (2008).
41. Silver, J. S. & Hunter, C. A. gp130 at the nexus of inflammation, autoimmunity, and cancer. J. Leukoc. Biol. 88, 1145-1156 (2010).
42. Knight, D. Leukaemia inhibitory factor (LIF): a cytokine of emerging importance in chronic airway inflammation. Pulm. Pharmacol. Ther. 14, 169-176 (2001). (Pubitemid 32619921)
43. Moodley, Y. P. et al. Fibroblasts isolated from normal lungs and those with idiopatic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am. J. Pathol. 163, 345-354 (2003). (Pubitemid 36759619)
44. Fayon, M. et al. Increased secretion of leukemia inhibitory factor by immature airway smooth muscle cells enhances intracellular signaling and airway contractility. Am. J. Physiol. Lung. Cell. Mol. Physiol. 291, L244-L251 (2006). (Pubitemid 44148108)
45. Marini, M ., Vittori, E ., Hollemborg, J. & Mattoli, S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin. Immunol. 89, 1001-1009 (1992).
46. Pégorier, S ., Arouche, N ., Dombret, M .- C ., Aubier, M. & Pretolani, M. Augmented epithelial endothelin-1 expression in refractory asthma. J. Allergy Clin. Immunol. 120, 1301-1307 (2007). (Pubitemid 350216607)
47. Jayaram, L. et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur. Respir. J. 27, 483-494 (2006). (Pubitemid 43372521)
48. Hastie, A. T. et al. Analysis of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J. Allergy. Clin. Immunol. 125, 1028-1036 (2010).
49. Feezor, R. J. et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol. Genomics 19, 247-254 (2004).